Pyridoxine and riboflavin status in the Paterson-Kelly syndrome.
D000328:Adult; D000368:Aged; D000747:Anemia, Hypochromic / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D003680:Deglutition Disorders / Q000097:blood / Q000150:complications; D004912:Erythrocytes / Q000032:analysis / Q000201:enzymology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011732:Pyridoxal Phosphate / Q000627:therapeutic use; D011736:Pyridoxine / Q000097:blood*; D012256:Riboflavin / Q000097:blood*; D012257:Riboflavin Deficiency / Q000150:complications; D000637:Transaminases / Q000032:analysis; D014364:Tryptophan / Q000652:urine
D011732:Pyridoxal Phosphate; D014364:Tryptophan; D000637:Transaminases; D011736:Pyridoxine; D012256:Riboflavin